Nectar Lifesciences information

Nectar Lifesciences Limited
Company type	Public
Traded as	BSE: 532649; NSE: NECLIFE
Industry	Pharmaceuticals
Founded	1995
Headquarters	Chandigarh, India
Key people	Sanjiv Goyal (Chairman); Dinesh Dua (ED); Sandeep Goel (CFO); Amit Chadah (CEO); Sunder Lal (Company secretary);
Products	Pharmaceuticals,
Revenue	₹ 31.14 billion
Net income	₹ 1.05 billion
Number of employees	2200
Website	www.neclife.com

Nectar Lifesciences Limited is a pharmaceutical company in India that manufactures generic drug products.^[1] The company has global leadership in several oral and sterile cephalosporin drugs, and has cGMP facilities along with those approved by the European Union and Japan.^[2]

^ "NECTAR LIFESCIENCES LTD (NECLIFE:National Stock Exchange of India): Stock Quote & Company Profile - Businessweek". investing.businessweek.com. Archived from the original on 18 January 2013. Retrieved 28 September 2012.
^ "Nectar Lifesciences Limited (Neclife) Receives Anvisa Approval For Its Cephalosporin API's Manufacturing Facility". Institute of Good Manufacturing Practices India. Retrieved 1 July 2018.

[1] "NECTAR LIFESCIENCES LTD (NECLIFE:National Stock Exchange of India): Stock Quote & Company Profile - Businessweek". investing.businessweek.com. Archived from the original on 18 January 2013. Retrieved 28 September 2012.

[2] "Nectar Lifesciences Limited (Neclife) Receives Anvisa Approval For Its Cephalosporin API's Manufacturing Facility". Institute of Good Manufacturing Practices India. Retrieved 1 July 2018.

Nectar Lifesciences information

and 11 Related for: Nectar Lifesciences information

Nectar Lifesciences

Pharmaceutical industry in Gujarat

List of companies of India

List of companies listed on the National Stock Exchange of India

New Silk Route

Brown violetear

Green hermit

Little hermit

Blue dacnis

Jamaican fruit bat

Biota of Trinidad and Tobago